Le Lézard
Classified in: Science and technology
Subjects: PDT, SBS

Industry First Voice Security Best Practices Now Available to Address New and Escalating Cybersecurity Threat Vector


CHICAGO, Feb. 28, 2024 /PRNewswire/ -- Mutare, Inc. (Mutare), a leading innovator of enterprise solutions for Voice Threat Defenseannounced today the release of a new set of comprehensive best practices to guide and direct organizations across the globe in response to the challenges posed by the growing cacophony of voice-centric cyber-attacks.  The Foundational Best Practices for Voice Cybersecurity includes guidance and direction for adding Voice Security into existing cybersecurity and risk management strategies, policies, and practices.

Voice is one of the fastest-growing cybersecurity threat vectors, but organizations have been disastrously slow to react, leaving a gap in the Attack Surface. The Foundational Best Practices for Voice Cybersecurity provides direction for enterprise-class organizations to better understand:

Vishing, social engineering, GenAI, spoof calls, voice spam storms and robocalls are some of the more well-known voice-centric attack types plaguing organizations of all sizes and in every industry sector. The Foundational Best Practices for Voice Cybersecurity provides comprehensive guidelines that organizations can follow to adequately defend and protect against these, and other, ever-evolving cyber threats targeting the voice channel.

The Foundational Best Practices for Voice Cybersecurity has been structured for an enterprise-wide approach, where disparate operating units (Information Technology, Security & Risk Management, and Contact Center) come together for an aligned and integrated defense. Included are sixteen practical best practices to help organizations reduce their organizational risk, protect their people, physical assets, and digital assets. 

Evolving regulatory and legal precedents have highlighted the importance of having measures in place to protect and defend the voice channel. While governments are working to rapidly enact new regulations, the legal system may hold the most significant pulpit, answering to a growing tide of cyber-breach class action lawsuits based on whether an organization has appropriated "reasonable" cybersecurity measures to protect customer data. Most organizations have little or no protections in place for the voice channel, and voice is rarely included in cybersecurity and risk management programs, policies and security infrastructure.

About Mutare
For three decades, Mutare has been empowering organizations to re-imagine a better way to connect. Today, through our transformative voice security, digital voice and text messaging solutions, we make communications with colleagues, customers and prospects simple, secure and effective. And that means more time and less stress for your employees, a more positive experience for your customers, and improved bottom line results for your organization. Our forward-looking leadership team is made up of dedicated, focused and experienced people who care about transforming business communications and improving the lives of others. Ultimately, we are dedicated to making a difference for all our stakeholders ? team members, customers, partners and communities. We are changemakers who are committed to becoming the recognized leader in voice threat defense for the enterprise.

MEDIA CONTACT

Colin Millstone
Chief Marketing Officer
(314) 913-4238
[email protected]

SOURCE Mutare, Inc.


These press releases may also interest you

1 jun 2024
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released updated data of its novel drug candidate...

1 jun 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

1 jun 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and other major...

1 jun 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

1 jun 2024
GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, today announced the phase II trial data of KROCUS Study, fulzerasib (GFH925, KRAS G12C inhibitor) in combination with...

1 jun 2024
Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide therapeutics to address oncogenic and immune dysregulation that drive cancer, today...



News published on and distributed by: